EDGAR Filing Documents for 0001437749-23-019729

Form S-4/A - Registration of securities, business combinations: [Amend]

SEC Accession No. 0001437749-23-019729

Filing Date

2023-07-12

Accepted

2023-07-11 19:38:33

Documents

116

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-4/A	dffn20230706_s4a.htm iXBRL	S-4/A	6268469
2	EXHIBIT 4.12	ex_542005.htm	EX-4.12	127702
3	EXHIBIT 23.1	ex_541643.htm	EX-23.1	2240
4	EXHIBIT 23.2	ex_541644.htm	EX-23.2	2665
5	EXHIBIT 99.7	ex_542229.htm	EX-99.7	1817
6	EXHIBIT 99.8	ex_541650.htm	EX-99.8	6454
12		cglogo.jpg	GRAPHIC	9347
13		dp01.jpg	GRAPHIC	7518
14		eippharma01.jpg	GRAPHIC	7573
15		graph01.jpg	GRAPHIC	12989
16		graph02.jpg	GRAPHIC	17525
17		graph04.jpg	GRAPHIC	23632
18		graph05.jpg	GRAPHIC	43499
19		graph07.jpg	GRAPHIC	13761
20		graph08.jpg	GRAPHIC	19130
21		graph09.jpg	GRAPHIC	36727
22		graph10.jpg	GRAPHIC	25635
23		graph11.jpg	GRAPHIC	15172
24		graph12.jpg	GRAPHIC	15839
25		image02.jpg	GRAPHIC	675
26		p01.jpg	GRAPHIC	476248
27		p02.jpg	GRAPHIC	626235
28		pic1.jpg	GRAPHIC	71589
29		pic2.jpg	GRAPHIC	75736
	Complete submission text file	0001437749-23-019729.txt		15984958

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	dffn-20230331.xsd	EX-101.SCH	70312
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	dffn-20230331_def.xml	EX-101.DEF	519148
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	dffn-20230331_lab.xml	EX-101.LAB	284488
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	dffn-20230331_pre.xml	EX-101.PRE	561199
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	dffn-20230331_cal.xml	EX-101.CAL	49584
109	EXTRACTED XBRL INSTANCE DOCUMENT	dffn20230706_s4a_htm.xml	XML	1060710

Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902

Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718

Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)